Free Newsletter
FDA reform doesn't top Obama's list
After years of food poisoning episodes, tainted imports and unrealized promises of reform, the incoming Obama administration has been saying the embattled FDA would finally get what it needed. But now, some of the leading champions of rebuilding the agency and the food safety system acknowledge that big reforms are likely still years away. Report
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline


SHARE
WITH: